2026 ASENT Annual Meeting Abstract Submissions

Submitting a Late-Breaking Abstract to ASENT

Deadline: January 31, 2026 at 11:59PM ET

The Abstract Review Committee is committed to presenting the best in neurotherapeutic research at the ASENT Annual Meeting. All abstracts are evaluated by experts in neurotherapeutics according to the following criteria and overall merit:

1. Scientific or clinical impact
2. Quality of data, analysis, and presentation
3. Relevance to the discovery and/or development of neurotherapeutics and inclusion of novel targets or new initiatives.
4. Abstracts must be submitted, presented, and cited in English.

The abstract should describe original research broadly relevant to the goal of ASENT, which is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system. Please check your abstract carefully for typographical errors, misspellings, etc. Be sure to include data or results when available.

FAQs on Eligibility

• ASENT welcomes encore abstracts, or those abstracts that have been previously presented at other recent scientific meetings, or submitted for consideration to other scientific meetings.
• Trainees and early career researchers are highly encouraged to submit
• All sectors (academic, industry, government, etc.) are welcome to submit
• Trial designs or trials-in-progress are welcome and considered 
• Case Studies or Case Reports will not be considered
  
  

If Accepted

One presenting author must be designated to attend the Annual Meeting in person. All attendees must register to attend the meeting via asent.org separate from this form. 

Poster Presentations
If your abstract is selected for a poster, you will need to be available to participate in our poster presentation at the annual meeting. This is scheduled to take place on Wednesday, March 4, 2026.

Oral Presentations
Submitted abstracts that most closely conform to the above criteria and the ASENT goals, may also be selected for a 10-minute oral presentation (including 2 minute Q&A) at our Oral Presentation session. ASENT encourages abstracts from private, public, and startup companies and government or academic labs that conduct neurotherapeutic research.

About the Meeting
The ASENT Annual Meeting attracts a broad spectrum of researchers, clinicians, investors, and other leaders in neurotherapeutics from all over the world, across all neurologic disease areas. Oral presentations increase exposure to strategic partners in life sciences who have supported novel approaches through partnerships or strategic investments.

For questions regarding abstracts, please email aditya.joshi@pennmedicine.upenn.edu